FNA - paragon28.com Enterprise Value

Brandmark of paragon28.com (FNA)

Product recall risks and insurance issues could slow revenue growth, as illustrated by the share price history where the Enterprise Value stands at . Paragon 28, Inc. (FNA) relies on the expansion of digital platforms and the broadening of its implant portfolio. The business generates revenue by supplying orthopedic foot and ankle solutions, targeting an aging population and the development of sports medicine.

Total Company Value: Paragon 28 Inc. (FNA) for 07/04/2022 - 10/29/2026

Paragon 28 (FNA) - metric breakdowns and financial figures

- share price and expert price forecast:
Share Price Paragon 28 Inc.|FNA - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Paragon 28|FNA - Total Company Value
- book value of equity indicators:
Net Assets per Share Paragon 28|FNA - Company Book Value|Market Capitalization to Net Assets paragon28.com|FNA - Company Total Assets
- debt level and financial liquidity data:
Debt to Capital Paragon 28, Inc.|FNA - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Paragon 28 Inc.|FNA - Company Aggregate Debts|Debts to Net Assets Paragon 28|FNA - Company Long-Term Debts|Company Short-Term Debts Paragon 28|Quick Liquidity paragon28.com
- company profitability and valuation multiples indicators:
FNA - Net Profit
Summary company analytics:FNA Paragon 28, Inc.
Manufactured product of Paragon 28 Corp

To assess the issuer's financial stability, it is critical to analyze the Enterprise Value, which combines market capitalization and net debt to determine the total acquisition cost of the business. The Enterprise Value trend on this chart allows for a correlation between the real price of Paragon 28, Inc. (FNA) and its dominance in the foot implant niche, separating the fundamental value of the market leader from short-term price fluctuations.

Who Paragon 28, Inc. competes with

BSX: Business Value|Edwards Lifesciences Corp - Enterprise Value|RMD - Enterprise Value|Insulet Corporation (PODD) - Total Company Value|ZBH - Company Buyout Price|Total Company Value CooperCompanies|Invisalign - Full Business Value|Enterprise Value GMED|TMDX - Total Enterprise Value|Enterprise Value ATEC (Alphatec Holdings, Inc.)|AORT - Real Price to Acquire Entire Company|Enovis - Enterprise Value|Company Buyout Price Integra LifeSciences Corp IART|ESTA: Enterprise Value|iLet Bionic Pancreas (BBNX) - Enterprise Value|Total Company Value IRADIMED CORPORATION|Total Company Value EMBC|Enterprise Value TNDM|Company Buyout Price AxoGen Inc|SI-BONE Corp - Real Price to Acquire Entire Company|OFIX (Orthofix Corp) - Full Business Value|Bioventus Inc. - Enterprise Value|Total Enterprise Value OrthoPediatrics Corp.|TMCI: Enterprise Value|Business Value SRTA|Real Price to Acquire Entire Company CARL|RXST: Value Adjusted for Debt and Cash|Total Company Value ClearPoint Neuro, Inc. (CLPT)|Real Price to Acquire Entire Company stereotaxis.com STXS|Enterprise Value STIM (Neuronetics)|Sight Sciences Inc. (SGHT) - Total Enterprise Value|Orchestra BioMed, Inc. - Enterprise Value|ANIK (Anika Therapeutics) - Business Value|NSPR: Enterprise Value|ZJYL - Company Buyout Price|VANI (Vivani Medical Inc) - Enterprise Value|Real Price to Acquire Entire Company Xtant Medical Inc (XTNT)|Enterprise Value NMTC|Enterprise Value modular-medical.com (MODD)|Total Company Value Myomo, Inc. MYO|envoymedical.com - Total Company Value|VVOS: Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash NVNO (enVVeno Medical Corporation)|SINT: Enterprise Value|Total Enterprise Value Tenon Medical Inc (TNON)|Total Company Value ReWalk Robotics Ltd.|AMIX - Full Takeover Company Value|Real Price to Acquire Entire Company IVF (INVO Fertility)|Enterprise Value Bone Biologics Corp. (BBLG)|Enterprise Value AXNX (Axonics Modulation Technologies)|Company Buyout Price Biolase Inc. (BIOL)|DYNT - Total Company Value|Full Business Value INVO